Breast Cancer Risk Assessment

Research

The Women's Cancer Program of the Mayo Clinic Cancer Center is conducting a national research study on potential biomarkers that indicate which women with benign breast disease are at risk for eventually developing breast cancer. Funded by a Breast Cancer Center of Excellence grant from the Department of Defense Breast Cancer Research Program, this four-year study will look for molecular risk predictors in benign breast tissue. The study will draw upon tissue specimens taken from 12,000 women who had breast biopsies performed at Mayo Clinic between 1967 and 1991, and were found to have benign breast disease.